AP News

Correction: Ranbaxy Laboratories-CEO story

PLAINSBORO TOWNSHIP, N.J. (AP) — In a July 9 story about Indian drugmaker Ranbaxy Laboratories Ltd., The Associated Press erroneously reported that the company will launch a generic version of acne drug Accutane in about six months. The product is slightly different than Accutane and will be sold under the brand name Absorica.

Race, Class, and the Future of Ferguson

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus